- Home
- TRIB vs BRTX Comparison
TRIB vs BRTX Comparison
Compare TRIB & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- BRTX
- Stock Information
- Founded
- TRIB 1992
- BRTX 1997
- Country
- TRIB Ireland
- BRTX United States
- Employees
- TRIB N/A
- BRTX N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BRTX Managed Health Care
- Sector
- TRIB Health Care
- BRTX Health Care
- Exchange
- TRIB Nasdaq
- BRTX Nasdaq
- Market Cap
- TRIB 12.3M
- BRTX 11.3M
- IPO Year
- TRIB N/A
- BRTX N/A
- Fundamental
- Price
- TRIB $1.22
- BRTX $1.48
- Analyst Decision
- TRIB
- BRTX Strong Buy
- Analyst Count
- TRIB 0
- BRTX 1
- Target Price
- TRIB N/A
- BRTX $18.00
- AVG Volume (30 Days)
- TRIB 88.7K
- BRTX 38.0K
- Earning Date
- TRIB 11-15-2024
- BRTX 11-12-2024
- Dividend Yield
- TRIB N/A
- BRTX N/A
- EPS Growth
- TRIB N/A
- BRTX N/A
- EPS
- TRIB N/A
- BRTX N/A
- Revenue
- TRIB $59,126,000.00
- BRTX $377,000.00
- Revenue This Year
- TRIB $17.64
- BRTX $598.90
- Revenue Next Year
- TRIB $9.84
- BRTX $162.81
- P/E Ratio
- TRIB N/A
- BRTX N/A
- Revenue Growth
- TRIB N/A
- BRTX 189.55
- 52 Week Low
- TRIB $1.05
- BRTX $1.03
- 52 Week High
- TRIB $3.55
- BRTX $3.67
- Technical
- Relative Strength Index (RSI)
- TRIB 32.00
- BRTX 45.13
- Support Level
- TRIB $1.24
- BRTX $1.32
- Resistance Level
- TRIB $1.40
- BRTX $1.78
- Average True Range (ATR)
- TRIB 0.16
- BRTX 0.15
- MACD
- TRIB -0.05
- BRTX -0.01
- Stochastic Oscillator
- TRIB 4.11
- BRTX 47.37
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.